CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹23,249 Cr | ₹19,392 Cr | ₹16,805 Cr | ₹14,711 Cr | ₹13,181 Cr |
What is the latest Total Current Assets ratio of CIPLA ?
| Year | Total Current Assets |
|---|---|
| Mar2025 | ₹23,249 Cr |
| Mar2024 | ₹19,392 Cr |
| Mar2023 | ₹16,805 Cr |
| Mar2022 | ₹14,711 Cr |
| Mar2021 | ₹13,181 Cr |
How is Total Current Assets of CIPLA Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹23,249 Cr | 19.89 | |
| Mar2024 | ₹19,392 Cr | 15.40 | |
| Mar2023 | ₹16,805 Cr | 14.24 | |
| Mar2022 | ₹14,711 Cr | 11.61 | |
| Mar2021 | ₹13,181 Cr | - | |
Compare Total Current Assets of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹122,280.7 Cr | 0.2% | -0.6% | -3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,287.0 Cr | 0.2% | 2.3% | -9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹177,657.0 Cr | -1.3% | 9.1% | 16.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,202.0 Cr | 0.6% | 1% | 10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,024.0 Cr | 0.6% | -3.5% | -4.3% | Stock Analytics | |
| MANKIND PHARMA | ₹92,301.0 Cr | -5% | -8.8% | -14.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.2% |
-0.6% |
-3.8% |
| SENSEX | -0.5% |
2% |
4.8% |
You may also like the below Video Courses